Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis]. [electronic resource] by
- Evdoshenko, E P
- Neofidov, N A
- Bakhtiyarova, K Z
- Davydovskaya, M V
- Kairbekova, E I
- Kolontareva, Yu M
- Malkova, N A
- Odinak, M M
- Popova, E V
- Sazonov, D V
- Stolyarov, I D
- Smagina, I V
- Fedyanin, A S
- Habirov, F A
- Khaibullin, T I
- Khachanova, N V
- Shchukin, I A
- Boyko, A N
Producer: 20200218
In:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 119
Availability: No items available.
|
|
6.
|
[A comparative placebo-controlled clinical study on the efficacy and safety of interferon beta-1a for subcutaneous injections in patients with remitting multiple sclerosis: results of the first year of observations]. [electronic resource] by
- Boyko, A N
- Bosenko, L P
- Vasilovskiy, V V
- Volkova, L I
- Zakharova, M N
- Kotov, S V
- Lekomtseva, E V
- Negrich, T I
- Parshina, E V
- Patrusheva, O P
- Prokopenko, S V
- Sazonov, D V
- Timchenko, P V
- Trinitatskiy, Yu V
- Khabirov, F A
- Khavunka, M Ya
- Chichanovskaya, L V
- Sherman, M A
- Lin'kova, Yu N
- Zinkina-Orikhan, A V
- Tursunova, K B
Producer: 20190408
In:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 117
Availability: No items available.
|
|
7.
|
[Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a]. [electronic resource] by
- Boyko, A N
- Bosenko, L P
- Vasilovskiy, V V
- Volkova, L I
- Zakharova, M N
- Kotov, S V
- Lekomtseva, E V
- Negrich, T I
- Parshina, E V
- Patrusheva, O P
- Prokopenko, S V
- Sazonov, D V
- Timchenko, L V
- Trinitatskiy, Yu V
- Khabirov, F A
- Khavunka, M Ya
- Chichanovskaya, L V
- Sherman, M A
- Ivanov, R A
- Lin'kova, Yu N
- Stukalina, E Yu
- Zinkina-Orikhan, A V
- Obukhova, I G
Producer: 20190826
In:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 119
Availability: No items available.
|
|
8.
|
[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study]. [electronic resource] by
- Boyko, A N
- Lashch, N Yu
- Sharanova, S N
- Zakharova, M N
- Trifonova, O V
- Simaniv, T O
- Lysogorskaya, E V
- Guryanova, O E
- Kotov, S V
- Iakushina, T I
- Lizhdvoy, V Yu
- Belova, Yu A
- Khabirov, F A
- Babicheva, N N
- Khaibullin, T I
- Granatov, E V
- Averyanova, L A
- Sazonov, D V
- Odinak, M M
- Trinitatsky, Yu V
- Tsukurova, L A
- Sergeeva, A I
- Ivanov, R A
- Shustova, M S
Producer: 20181105
In:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova vol. 116
Availability: No items available.
|